Cardiff Oncology GAAP EPS of -$0.18 misses by $0.05, revenue of $0.04M misses by $0.04M
Cardiff Oncology, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $1.48
+12% in 7d after detection
Post-detection moves
1h
—
1d
-3.5%
3d
+1.7%
7d
+12%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS